Cell & Gene Therapy
Evolution of Cell Therapy and Immunotherapy
Rapid Growth of Cell Therapy
Driven by advancements in cell biology, immunology, molecular biology, and tissue engineering, cell immunotherapy has become one of the most dynamic areas in life sciences.
It is widely recognized as the “third pillar of modern medicine”, following pharmaceuticals and surgery.
CAR-T and TCR Technologies in Cancer Treatment
In tumor immunotherapy, cytotoxic T cells are genetically modified to express chimeric antigen receptors (CAR) or tumor antigen-specific T cell receptors (TCR).
These engineered cells can specifically recognize and eliminate cancer cells, establishing CAR-T cell therapy as the fourth major cancer treatment modality after surgery, chemotherapy, and radiotherapy.
Commercialization of
Cell Therapy
In 2017, the U.S. FDA approved Kymriah and Yescarta, the first commercial CAR-T therapies.
This breakthrough marked the transition of cell therapy from clinical trials to industrial application, accelerating global interest and investment in cell and gene therapy (CGT) technologies.
Tailin CGT
Manufacturing Solutions
To support the development of cell and gene therapy manufacturing,
Tailin offers a complete suite of equipment designed for aseptic cell processing, including:
- Cell & Gene Therapy Isolator (CGT Isolator)
- Honeycomb Cell Culture System
- Live Cell Imaging System
More
